References
- Tatemoto K, Mutt S., Efendic V, et al. Pancreastatin. a novel pancreatic peptide that inhibits insulin secretion. Nature 1986; 324: 476–8
- Efendic Tatemoto S., Mutt K. V., et al. Pancreastatin and islet hormone release. Proc Natl Acad Sci USA 1987; 84: 7257–60
- Ahren B, Tatemoto S., Lindskog K, et al. Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice. Diabetes 1988; 37: 281–5
- Funakoshi A, Kitani K., Miyasaka K, et al. Bioactivity of synthetic C-terminal fragment of rat pancreastatin on endocrine pancreas. Biochem Biophys Res Commun 1989; 158: 844–9
- Funakoshi Miyasaka A., Nakamura K. R., et al. Bioactivity of synthetic human pancreastatin on exocrine pancreas. Biochem Biophys Res Commun 1988; 156: 1237–42
- Ishizuka J, Isamu A, Poston G J., et al. Effect of pancreastatin on pancreatic endocrine and exocrine secretion. Pancreas 1989; 4: 217–81
- Miyasaka Funakoshi K. A., Nakamura R, et al. Effects of porcine pancreastatin on postprandial pancreatic exocrine secretion and endocrine functions in the conscious rat. Digestion 1989; 43: 204–11
- Lewis Zdon J. IMJ, Adrian T E., et al. Pancreastatin: a novel peptide inhibitor of parietal cell secretion. Surgery 1988; 104: 1031
- Fasciotto B H., Gorr S U., DeFranco D J., et al. Pancreastatin, a persumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture. Endocrinology 1989; 125: 1617–22
- Iacangelo A, Fischer-Colbrie R, Koller K J., et al. The sequence of porcine chromogranin A messenger RN A demonstrates chro-mogranin A can serve as the precursor for the biologically active hormone, pancreastatin. Endocrinology 1988; 122: 2339–41
- Shimizu F, Ikei N, Iwanaga T, et al. An immunochemical and immunohistochemical study on pancreastatin-like immuno-reactivity using synthetic peptides. Biomed Res 1987; 8: 457–62
- Bretherton-Watt D, Ghatei M A., Bishop A E., et al. Pancreastatin distribution and plasma levels in the pig. Peptides 1988; 9: 1005–14
- Schmidt W E., Siegel E G., Lamberts R, et al. Pancreastatin: molecular and immuncytochemical characterization of a novel peptide in porcine and human tissues. Endocrinology 1988; 123: 1395–404
- Kar S, Bretherton-Watt Gibson S J., et al. Novel peptide pancreastatin: its occurrence and codistribution with chromogranin A in the central nervous system of the pig. J Comp Neurol 1989; 288: 627–39
- Børglum Jensen T D., Fahrenkrug J, Sundler F. Immu-nocytochemical localization of pancreastatin and chromogranin A in porcine neuroendocrine tissues. Regul Pept 1991; 36: 283–97
- Børglum Jensen T D., Hoist J J., Fahrenkrug J. Characterization of immunoreactive pancreastatin in porcine tissues. Scand J Clin Lab Invest 1991; 51: 681–91
- Lamberts R, Schmidt W E., Creutzfeldt W. Light and electron microscopical immunocytochemical localization of pancreastatin-like immunoreactivitv in porcine tissues. Histochemistry 1990; 93: 369–80
- O'Connor D T., Burton D, Deftos L J. Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues. J Clin Endocr Metab 1983; 57: 1984–6
- O'Connor D T., Frigon R P. Chromogranin A, the major catecholamine storage vesicle soluble protein. J Biol Chem 1984; 259: 3237–47
- Somogyi P, Hodtgson A J., De Potter R W., et al. Chromogranin immunoreactivit'y in the central nervous system. Immunochemical characterization, distribution and relationship to catecholamine andj enkephalin pathways. Brain Res Rev 1984; 8: 193–230
- Rindi Buffa G. R., Sessa A, et al. Chromogranin A, B, and C immunoreactivities of mammalian endocrine cells. Histochemistry 1986; 85: 19–28
- Facer P, Bishop A E., Lloyd R V., et al. Chromogranin: a newly recognized marker for endocrine cells of the human gastrointestinal tract. Gastroenterology 1985; 89: 1366–73
- Winkler H, Apps D K., Fischer-Colbrie R. The molecular function of adrenal chromaffin granules; established facts and unresolved topics. Neuroscience 1986; 18: 261–90
- Hutton J C., Davidson H W., Peshavaria M. The mechanism of chromogranin A processing. Nature 1987; 325: 766
- Hoist J J., Fahrenkrug J, Knuhtsen S. Vasoactive intestinal polypeptide (VIP) in the pig pancreas: role of VIPergic nerves in control of fluid and bicarbonate secretion. Regul Pept 1984; 8: 245–59
- Jensen S L., Fahrenkrug J, Hoist J, et al. Secretory effects of secretin on isolated perfused porcine pancreas. Am J Physiol 1978; 235: E381–6
- Hoist J J., Jensen S L., Knuhtsen S, et al. Effect of vagus, gastric inhibitory polypeptide, and HCL on gastrin and somatostatin release from perfused pig antrum. Am J Physiol 1983; 244: G515–22
- Skak-Nielsen T, Hoist J J., Nielsen O V. Role of gastrin-releasing peptide in the neural control of pepsinogen secretion from the pig stomach. Gastroenterology 1988; 95: 1216–20
- Messell T, Harling H, Poulsen S S., et al. Extrinsic control of the release of galanin and VIP from intrinsic nerves of isolated, perfused, porcine ileum. Regul Pept 1992; 38: 179–98
- Borglum Jensen T D., Fahrenkrug J, Hoist J J. Secretion of pan-creastatins from isolated, perfused, porcine adrenal glands. Peptides 1993, In press
- Huttner W B., Gerdes H H., Rosa P. The granin (chromogranin/ secretogranin) family. TIBS 1991; 16: 27–30
- Aardal S, Helle K B. The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence from extracellular calcium in isolated segments of human blood vessels. Regul Pept 1992; 41: 9–18
- Gorr S U., Shioi J, Cohn D V. Interaction of calcium with porcine adrenal chromogranin A (secretory protein-I) and chromogranin B (secretogranin I). Am J Physiol 1989; 257: E247–54
- Seidah N G., Hendy G N., Hamelin J, et al. Chromogranin A can act as a reversible processing enzyme inhibitor. FEBS Lett 1987; 211: 144–50
- Ostenson C G., Efendic S, Hoist J J. Pancreastatin-like immuno-reactivity and insulin are released in parallel from the perfused porcine pancreas. Endocrinology 1989; 124: 2986–90
- Hoist J J., Knuhtsen S, Orskov C, et al. GRP-producing nerves control antral somatostatin and gastrin secretion in pigs. Am J Physiol 1987; 253: G767–74
- Curry W J., Johnston C F., Shaw C, Buchanan K D. Distribution and partial characterization of immunoreactivity to the putative C-terminus of rat pancreastatin. Regul Pept 1990; 30: 207–19
- Hoist J J., Skak-Nielsen T, Ørskov C, et al. Vagal control of the release of somatostatin, vasoactive intestinal polypeptide, gastrin-releasing peptide, and HCL from porcine non-antral stomach. Scand J Gastroenterol 1992; 27: 677–85
- Sandvik A K., Kleveland P M., Waldum H L. Muscarinic M2 stimulation releases histamine in the totally isolated, vascularly perfused rat stomach. Scand J Gastroenterol 1988; 23: 1049–56
- Nylander O, Berggvist E, Obrink K J. Dual inhibitory actions of somatostatin on isolated gastric glands. Acta Physiol Scand 1985; 125: 111–9